Login / Signup

Nanotherapies for Treatment of Cardiovascular Disease: A Case for Antioxidant Targeted Delivery.

Ana CartayaSophie MaiocchiEdward M Bahnson
Published in: Current pathobiology reports (2019)
This review underscores the potential of targeted nanocarriers as means of finding success translating antioxidant therapies to the clinic, all with a focus on CVD.
Keyphrases
  • cardiovascular disease
  • oxidative stress
  • cancer therapy
  • anti inflammatory
  • drug delivery
  • type diabetes
  • metabolic syndrome
  • drug release
  • risk assessment
  • climate change